Drug Profile
Research programme: farnesoid-X-activated receptor agonists - Metacrine
Alternative Names: M 480Latest Information Update: 28 Jul 2022
Price :
$50
*
At a glance
- Originator Metacrine
- Class Anti-inflammatories; Antifibrotics; Hepatoprotectants; Small molecules
- Mechanism of Action Farnesoid X-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Fibrosis; Inflammatory bowel diseases; Irritable bowel syndrome; Non-alcoholic steatohepatitis
Most Recent Events
- 28 Jul 2022 No recent reports of development identified for preclinical development in Inflammatory-bowel-diseases in USA (PO)
- 28 Jun 2022 No recent reports of development identified for research development in Irritable-bowel-syndrome in USA
- 28 Nov 2021 No recent reports of development identified for preclinical development in Fibrosis in USA